Ten-year Experience of Bexarotene Therapy for Cutaneous T-cell Lymphoma in Finland

By Väkevä Liisa   Ranki Annamari   Hahtola Sonja  

Acta Dermato-Venereologica, Vol. 92, Iss. 3, 2012-05 ,pp. : 258-263

Medical Journals Limited

Access to resources Recommend Favorite

Extracutaneous Tumour Mass Following Bexarotene and Interferon Therapy of Primary Cutaneous CD30+ Large Cell Lymphoma

By Kreuter Alexander   Altmeyer Peter   Gambichler Thilo  

Acta Dermato-Venereologica, Vol. 86, Iss. 3, 2006-05 ,pp. : 274-275

Medical Journals Limited

Access to resources Recommend Favorite

Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin

By Kontochristopoulos G J   Exadaktylou D   Hatziolou E   Tassidou A   Zakopoulou N  

Journal of Dermatological Treatment, Vol. 12, Iss. 2, 2001-06 ,pp. : 117-121

Informa Healthcare

Access to resources Recommend Favorite

New Insights into Associated Co-morbidities in Patients with Cutaneous T-cell Lymphoma (Mycosis Fungoides)

By Hodak Emmilia   Lessin Stuart   Friedland Rivka   Freud Tamar   David Michael   Pavlovsky Lev   Shapiro Jonathan   Cohen Arnon D.  

Acta Dermato-Venereologica, Vol. 93, Iss. 4, 2013-07 ,pp. : 451-455

Medical Journals Limited

Access to resources Recommend Favorite

Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment

By  

Acta Dermato-Venereologica, Vol. 78, Iss. 2, 1998-08 ,pp. : 159-159

Medical Journals Limited

Access to resources Recommend Favorite